OncoArendi Therapeutics SA's total assets for Q1 2025 were zł107.45M, a decrease of -5.52% from the previous quarter. DE:1B1 total liabilities were zł9.24M for the fiscal quarter, a -10.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.